InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Ernexa Therapeutics Inc.

ERNA Clue Score32
United States Fiscal year ends December CIK 0000748592
$2.40 -3.61% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.40 −71.76% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue22.3Operating income−2.3Net income−2.9Fiscal year 2017Revenue21.3 −4.7%Operating income−1.4Net income−1.1Fiscal year 2018Revenue23.3 +9.7%Operating income0.2Net income−0.3Fiscal year 2019Revenue19.8 −15.1%Operating income−1.8Net income−2.0Fiscal year 2020Revenue5.8 −70.7%Operating income−7.2Net income−7.3EPS, diluted−0.41Fiscal year 2021Operating income−113.7Net income−122.5EPS, diluted−56.61Fiscal year 2022Revenue0.0Operating income−33.2Net income−24.6EPS, diluted−8.06Fiscal year 2023Revenue0.1Operating income−21.1Net income−21.7EPS, diluted−4.08Fiscal year 2024Revenue0.6 +755.9%Operating income−15.7Net income−44.5EPS, diluted−48.96Fiscal year 2025Operating income−9.3Net income−14.1EPS, diluted−2.24
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 22.3 21.3 23.3 19.8 5.8 n/a 0.0 0.1 0.6 n/a
Growth −4.7% +9.7% −15.1% −70.7% +755.9%
Operating income −2.3 −1.4 0.2 −1.8 −7.2 −113.7 −33.2 −21.1 −15.7 −9.3
Net income −2.9 −1.1 −0.3 −2.0 −7.3 −122.5 −24.6 −21.7 −44.5 −14.1
Growth
EPS, diluted n/a n/a n/a n/a −0.41 −56.61 −8.06 −4.08 −48.96 −2.24

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Operating margin−10.2%Net margin−13.1%Free cash flow margin−1.8%Fiscal year 2017Operating margin−6.6%Net margin−5.1%Free cash flow margin−0.8%Fiscal year 2018Operating margin0.9%Net margin−1.1%Free cash flow margin3.1%Fiscal year 2019Operating margin−8.9%Net margin−10.3%Free cash flow margin13.2%Fiscal year 2020Operating margin−125.0%Net margin−125.7%Free cash flow margin−140.3%Fiscal year 2021Fiscal year 2022Fiscal year 2023Gross margin−247.1%Operating margin−31,080.9%Net margin−31,864.7%Free cash flow margin−30,039.7%Fiscal year 2024Gross margin83.5%Operating margin−2,693.1%Net margin−7,652.7%Free cash flow margin−2,784.4%Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a n/a n/a n/a n/a −247.1% 83.5% n/a
Operating margin −10.2% −6.6% 0.9% −8.9% −125.0% n/a n/a −31,080.9% −2,693.1% n/a
Net margin −13.1% −5.1% −1.1% −10.3% −125.7% n/a n/a −31,864.7% −7,652.7% n/a
Free cash flow margin −1.8% −0.8% 3.1% 13.2% −140.3% n/a n/a −30,039.7% −2,784.4% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow0.0Capital expenditure−0.4Free cash flow−0.4Fiscal year 2017Operating cash flow0.5Capital expenditure−0.7Free cash flow−0.2Fiscal year 2018Operating cash flow1.4Capital expenditure−0.6Free cash flow0.7Fiscal year 2019Operating cash flow2.7Capital expenditure−0.1Free cash flow2.6 +264.9%Fiscal year 2020Operating cash flow−8.1Capital expenditure−0.0Free cash flow−8.1 −411.2%Fiscal year 2021Operating cash flow−23.5Capital expenditure−0.2Free cash flow−23.6Fiscal year 2022Operating cash flow−21.0Capital expenditure−0.3Free cash flow−21.3Fiscal year 2023Operating cash flow−20.4Capital expenditure−0.0Free cash flow−20.4Fiscal year 2024Operating cash flow−15.8Capital expenditure−0.4Free cash flow−16.2Fiscal year 2025Operating cash flow−7.0Capital expenditure−0.0Free cash flow−7.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 0.0 0.5 1.4 2.7 −8.1 −23.5 −21.0 −20.4 −15.8 −7.0
Capital expenditure −0.4 −0.7 −0.6 −0.1 −0.0 −0.2 −0.3 −0.0 −0.4 −0.0
Free cash flow −0.4 −0.2 0.7 2.6 −8.1 −23.6 −21.3 −20.4 −16.2 −7.1
Growth +264.9% −411.2%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash5.7Total debt11.1Net cash (debt)−5.4Shareholders’ equity4.1Debt to equity2.73Fiscal year 2017Cash3.4Total debt10.2Net cash (debt)−6.8Shareholders’ equity5.5Debt to equity1.84Fiscal year 2018Cash2.5Total debt4.8Net cash (debt)−2.2Shareholders’ equity6.9Debt to equity0.69Fiscal year 2019Cash3.2Total debt2.7Net cash (debt)0.5Shareholders’ equity9.7Debt to equity0.28Fiscal year 2020Cash0.8Total debt2.0Net cash (debt)−1.3Shareholders’ equity7.7Debt to equity0.27Fiscal year 2021Cash17.0Shareholders’ equity25.5Fiscal year 2022Cash11.4Shareholders’ equity12.1Fiscal year 2023Cash7.6Shareholders’ equity2.2Fiscal year 2024Cash1.7Shareholders’ equity1.7Fiscal year 2025Cash1.9Shareholders’ equity2.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 5.7 3.4 2.5 3.2 0.8 17.0 11.4 7.6 1.7 1.9
Total debt 11.1 10.2 4.8 2.7 2.0 n/a n/a n/a n/a n/a
Net cash (debt) −5.4 −6.8 −2.2 0.5 −1.3 n/a n/a n/a n/a n/a
Shareholders’ equity 4.1 5.5 6.9 9.7 7.7 25.5 12.1 2.2 1.7 2.4
Debt to equity 2.73 1.84 0.69 0.28 0.27 n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
22.3 21.3 23.3 19.8 5.8 n/a 0.0 0.1 0.6 n/a
Growth −4.7% +9.7% −15.1% −70.7% +755.9%
n/a n/a n/a n/a n/a n/a 0.0 0.2 0.1 n/a
n/a n/a n/a n/a n/a n/a 0.0 −0.2 0.5 n/a
Growth
n/a 0.1 0.1 0.0 0.0 n/a n/a n/a n/a n/a
16.5 15.6 14.5 13.2 8.1 14.7 16.8 14.6 13.1 5.2
−2.3 −1.4 0.2 −1.8 −7.2 −113.7 −33.2 −21.1 −15.7 −9.3
Growth −968.0%
−2.9 −1.0 −0.3 −2.0 −7.3 −122.5 −24.5 −21.7 −44.5 −14.1
0.0 0.1 −0.1 0.0 0.0 0.1 0.0 −0.0 0.0 −0.0
−2.9 −1.1 −0.3 −2.0 −7.3 −122.5 −24.6 −21.7 −44.5 −14.1
Growth
Per share
n/a n/a n/a n/a −0.41 −56.61 −8.06 −4.08 −48.96 −2.24
n/a n/a n/a n/a −0.41 −56.61 −8.06 −4.08 −48.96 −2.24
Growth
n/a n/a n/a n/a 17.6 2.2 3.1 5.3 0.9 6.3
n/a n/a n/a n/a 17.6 2.2 3.1 5.3 0.9 6.3
Growth −87.7% +40.9% +74.2% −82.9% +593.1%

† The diluted share count jumps at 2021 and 2023 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 52.2% a year over five years.
  • Operating margin is down 2,694.0 points on five years ago, at -2,693.1%.
  • A net loss in 10 of 10 years on file.